ORLANDO -- Adding another twist to the ongoing debate about the effects of weight-loss drugs on vision, a retrospective cohort study linked GLP-1 receptor agonists to a lower risk of legal blindness ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback